Straits Times Index
3,323.38 +0.18 (+0.01%) S&P 500
5,249.79 -17.16 (-0.33%) Dow
38,065.16 -376.38 (-0.98%) Nasdaq
16,859.45 -61.13 (-0.36%) Bitcoin USD
68,690.67 +853.91 (+1.26%) CMC Crypto 200
1,472.20 +16.34 (+1.12%)
ANIP Jul 2024 60.000 call
- GlobeNewswire
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows: Date:June 5, 2024 Time:4:30 ET Webcast:Click Here To schedule a 1x1 meeting with the Company, please contact your Jefferies representative. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified bio
- Zacks
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
- Zacks
Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
